Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 444

1.

Pathologic assessment of vasculopathies in pulmonary hypertension.

Pietra GG, Capron F, Stewart S, Leone O, Humbert M, Robbins IM, Reid LM, Tuder RM.

J Am Coll Cardiol. 2004 Jun 16;43(12 Suppl S):25S-32S. Review.

PMID:
15194175
[PubMed - indexed for MEDLINE]
Free Article
2.

Advances in the understanding and classification of pulmonary hypertension.

Stewart S, Rassl D.

Histopathology. 2009 Jan;54(1):104-16. doi: 10.1111/j.1365-2559.2008.03180.x. Review.

PMID:
19187180
[PubMed - indexed for MEDLINE]
3.

Cellular and molecular pathobiology of pulmonary arterial hypertension.

Humbert M, Morrell NW, Archer SL, Stenmark KR, MacLean MR, Lang IM, Christman BW, Weir EK, Eickelberg O, Voelkel NF, Rabinovitch M.

J Am Coll Cardiol. 2004 Jun 16;43(12 Suppl S):13S-24S. Review.

PMID:
15194174
[PubMed - indexed for MEDLINE]
Free Article
4.

Chronic hypoxia-induced pulmonary hypertension does/does not lead to loss of pulmonary vasculature.

Berg JT.

J Appl Physiol (1985). 2007 Oct;103(4):1455. No abstract available.

PMID:
17916681
[PubMed - indexed for MEDLINE]
Free Article
5.

Mechanisms of abnormal vasoreactivity in persistent pulmonary hypertension of the newborn infant.

Abman SH, Ivy DD, Ziegler JW, Kinsella JP.

J Perinatol. 1996 Mar-Apr;16(2 Pt 2 Su):S18-23. Review. No abstract available.

PMID:
8732544
[PubMed - indexed for MEDLINE]
6.

Pathology and aspects of pathogenesis in pulmonary arterial hypertension.

Dorfmüller P, Humbert M, Capron F, Müller KM.

Sarcoidosis Vasc Diffuse Lung Dis. 2003 Mar;20(1):9-19. Review.

PMID:
12737275
[PubMed - indexed for MEDLINE]
7.

Ion channels in pulmonary arterial hypertension.

Mandegar M, Remillard CV, Yuan JX.

Prog Cardiovasc Dis. 2002 Sep-Oct;45(2):81-114. Review.

PMID:
12411972
[PubMed - indexed for MEDLINE]
8.

Regression of flow-induced pulmonary arterial vasculopathy after flow correction in piglets.

Mercier O, Sage E, de Perrot M, Tu L, Marcos E, Decante B, Baudet B, Hervé P, Dartevelle P, Eddahibi S, Fadel E.

J Thorac Cardiovasc Surg. 2009 Jun;137(6):1538-46. doi: 10.1016/j.jtcvs.2008.07.069. Epub 2009 Feb 7.

PMID:
19464477
[PubMed - indexed for MEDLINE]
9.

Cellular and molecular biology of vascular smooth muscle cells in pulmonary hypertension.

Voelkel NF, Tuder RM.

Pulm Pharmacol Ther. 1997 Oct-Dec;10(5-6):231-41. Review. No abstract available.

PMID:
9778486
[PubMed - indexed for MEDLINE]
10.

Idiopathic pulmonary arterial hypertension: an avian model for plexogenic arteriopathy and serotonergic vasoconstriction.

Wideman RF Jr, Hamal KR.

J Pharmacol Toxicol Methods. 2011 May-Jun;63(3):283-95. doi: 10.1016/j.vascn.2011.01.002. Epub 2011 Jan 26.

PMID:
21277983
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Current insights on the pathogenesis of pulmonary arterial hypertension.

Perros F, Dorfmüller P, Humbert M.

Semin Respir Crit Care Med. 2005 Aug;26(4):355-64. Review.

PMID:
16121311
[PubMed - indexed for MEDLINE]
12.

[Normal and abnormal pulmonary circulation].

Tatsumi K.

Nihon Rinsho. 2008 Nov;66(11):2049-54. Review. Japanese.

PMID:
19051719
[PubMed - indexed for MEDLINE]
13.

[Update on the pathomorphological assessment of vasculopathies in pulmonary arterial hypertension].

Dorfmüller P, Humbert M, Capron F.

Pathologe. 2006 Mar;27(2):140-6. Review. German.

PMID:
16450085
[PubMed - indexed for MEDLINE]
14.

Hypoxic pulmonary hypertension: acute and chronic.

Thompson BT, Hales CA.

Heart Lung. 1986 Sep;15(5):457-65. No abstract available.

PMID:
3639074
[PubMed - indexed for MEDLINE]
15.

Potassium channel diversity in the pulmonary arteries and pulmonary veins: implications for regulation of the pulmonary vasculature in health and during pulmonary hypertension.

Bonnet S, Archer SL.

Pharmacol Ther. 2007 Jul;115(1):56-69. Epub 2007 Apr 21. Review.

PMID:
17583356
[PubMed - indexed for MEDLINE]
16.

Impact of vascular abnormalities in neoplastic and non-neoplastic lung disease.

Alexander MP, Rameshkumar K.

Indian J Chest Dis Allied Sci. 2005 Apr-Jun;47(2):103-7.

PMID:
15832954
[PubMed - indexed for MEDLINE]
17.

[The etiopathogenesis of pulmonary hypertension: inflammation, vascular remodeling].

Kayikçioğlu M.

Anadolu Kardiyol Derg. 2010 Aug;10 Suppl 1:5-8. doi: 10.5152/akd.2010.113. Review. Turkish.

PMID:
20819761
[PubMed - indexed for MEDLINE]
Free Article
18.

Increased resistance in postobstructive pulmonary vasculopathy: structure-function relationships.

Michel RP, Hakim TS.

J Appl Physiol (1985). 1991 Aug;71(2):601-10.

PMID:
1938734
[PubMed - indexed for MEDLINE]
19.

Pathology of chronic pulmonary hypertension.

Edwards JE.

Pathol Annu. 1974;9(0):1-25. No abstract available.

PMID:
4278878
[PubMed - indexed for MEDLINE]
20.

Management of pulmonary arterial hypertension associated with congenital systemic-to-pulmonary shunts and Eisenmenger's syndrome.

Galie N, Manes A, Palazzini M, Negro L, Marinelli A, Gambetti S, Mariucci E, Donti A, Branzi A, Picchio FM.

Drugs. 2008;68(8):1049-66. Review.

PMID:
18484798
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk